Cargando…
CPP-ZFN: A potential DNA-targeting anti-malarial drug
BACKGROUND: Multidrug-resistant Plasmodium is of major concern today. Effective vaccines or successful applications of RNAi-based strategies for the treatment of malaria are currently unavailable. An unexplored area in the field of malaria research is the development of DNA-targeting drugs that can...
Autores principales: | Nain, Vikrant, Sahi, Shakti, Verma, Anju |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949742/ https://www.ncbi.nlm.nih.gov/pubmed/20846404 http://dx.doi.org/10.1186/1475-2875-9-258 |
Ejemplares similares
-
Modeling of human M1 aminopeptidases for in silico screening of potential Plasmodium falciparum alanine aminopeptidase (PfA-M1) specific inhibitors
por: Sahi, Shakti, et al.
Publicado: (2014) -
Insights from molecular modeling and dynamics simulation of pathogen resistance (R) protein from brinjal
por: Shrivastava, Dipty, et al.
Publicado: (2011) -
Time to scale up molecular surveillance for anti-malarial drug resistance in sub-saharan Africa
por: Nsanzabana, Christian
Publicado: (2021) -
Is there evidence of anti-malarial multidrug resistance in Burkina Faso?
por: Rasmussen, Charlotte, et al.
Publicado: (2021) -
Inclusion of gametocyte parameters in anti-malarial drug efficacy studies: filling a neglected gap needed for malaria elimination
por: Abdul-Ghani, Rashad, et al.
Publicado: (2015)